SG/CALL/STRYKER CORP./440/0.1/20.09.24 Stock

Warrant

DE000SW7ENZ8

Real-time Bid/Ask 06:23:37 2024-05-24 am EDT
0.001 EUR / 0.12 EUR +6,000.00% Intraday chart for SG/CALL/STRYKER CORP./440/0.1/20.09.24
Current month-98.61%
1 month-98.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 0.001 0.00%
24-05-23 0.001 0.00%
24-05-22 0.001 0.00%
24-05-21 0.001 0.00%
24-05-20 0.001 0.00%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 03:58 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ENZ
ISINDE000SW7ENZ8
Date issued 2024-03-07
Strike 440 $
Maturity 2024-09-20 (119 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.47
Lowest since issue 0.001
Spread 0.119
Spread %99.17%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.1 USD
Average target price
372.4 USD
Spread / Average Target
+12.79%
Consensus